quinazolines has been researched along with Hypermelanosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fine, HA; Kong, HH; Stern, JB; Turner, ML | 1 |
| Brooks, S; Kong, HH; Linehan, WM; Srinivasan, R | 1 |
| How, CK; Huang, MS; Su, PH; Yen, DH | 1 |
| Arnault, JP; Baudin, E; Brassard, M; Giacchero, D; Maksimovic, L; Mateus, C; Ramacciotti, C; Robert, C; Schlumberger, M; Tomasic, G; Wechsler, J | 1 |
| Chang, GC; Chen, KC; Lin, YC; Wang, RC; Yang, TY; Yin, MC | 1 |
| Canning, MT; Dong, KK; Grimson, R; Smiles, KA; Walfield, AM; Yarosh, DB | 1 |
2 trial(s) available for quinazolines and Hypermelanosis
| Article | Year |
|---|---|
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.
Topics: Adult; Aged; Aged, 80 and over; Female; Folliculitis; Hand-Foot Syndrome; Humans; Hyperpigmentation; Male; Middle Aged; Photosensitivity Disorders; Piperidines; Protein Kinase Inhibitors; Quinazolines; Thyroid Neoplasms | 2012 |
A hydroquinone formulation with increased stability and decreased potential for irritation.
Topics: Adult; Alkaloids; Antioxidants; Cells, Cultured; Dermatitis, Irritant; Dermatologic Agents; Drug Combinations; Drug Stability; Ergothioneine; Female; Humans; Hydroquinones; Hyperpigmentation; Male; Melanins; Melanocytes; Quinazolines; Skin Irritancy Tests; Statistics, Nonparametric | 2007 |
4 other study(ies) available for quinazolines and Hypermelanosis
| Article | Year |
|---|---|
Cutaneous pigmentation after photosensitivity induced by vandetanib therapy.
Topics: Aged; Antineoplastic Agents; Dermatitis, Phototoxic; Female; Humans; Hyperpigmentation; Middle Aged; Piperidines; Protein-Tyrosine Kinases; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Skin | 2009 |
Successful laser treatment of vandetanib-associated cutaneous pigmentation.
Topics: Adult; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Hyperpigmentation; Lasers, Solid-State; Piperidines; Protein Kinase Inhibitors; Quinazolines; Skin Pigmentation | 2011 |
Melanonychia secondary to hydroxyurea.
Topics: Aged; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Hyperpigmentation; Nail Diseases; Platelet Aggregation Inhibitors; Plateletpheresis; Quinazolines; Risk Factors | 2012 |
Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer.
Topics: Adult; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Epidermal Growth Factor; Female; Gefitinib; Humans; Hyperpigmentation; Lung Neoplasms; Middle Aged; Paronychia; Protein-Tyrosine Kinases; Quinazolines | 2004 |